5.1-5.6 million Americans with depression may benefit from psilocybin therapy, pending FDA approval.
New research indicates that psilocybin, found in magic mushrooms, could help 5.1 to 5.6 million Americans with depression. While studies suggest psilocybin may alleviate symptoms, the FDA has yet to approve it for therapy. Currently considered for treatment-resistant depression, broader approval is possible. Researchers highlight the potential of psilocybin to aid in various mental health conditions when combined with talk therapy.
September 13, 2024
16 Articles